ATE409697T1 - 1,1a,5,5a-tetrahydro-3-thia- cyclopropaäaüpentalene: trizyklische thiophenderivate als s1p1/edg1-rezeptor-agonisten - Google Patents

1,1a,5,5a-tetrahydro-3-thia- cyclopropaäaüpentalene: trizyklische thiophenderivate als s1p1/edg1-rezeptor-agonisten

Info

Publication number
ATE409697T1
ATE409697T1 AT05772622T AT05772622T ATE409697T1 AT E409697 T1 ATE409697 T1 AT E409697T1 AT 05772622 T AT05772622 T AT 05772622T AT 05772622 T AT05772622 T AT 05772622T AT E409697 T1 ATE409697 T1 AT E409697T1
Authority
AT
Austria
Prior art keywords
cyclopropaäaüpentalene
thia
tetrahydro
receptor agonists
thiophene derivatives
Prior art date
Application number
AT05772622T
Other languages
English (en)
Inventor
Martin Bolli
Daniel Bur
Martine Clozel
Walter Fischli
David Lehmann
Boris Mathys
Claus Mueller
Oliver Nayler
Michael Scherz
Thomas Weller
Original Assignee
Actelion Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Actelion Pharmaceuticals Ltd filed Critical Actelion Pharmaceuticals Ltd
Application granted granted Critical
Publication of ATE409697T1 publication Critical patent/ATE409697T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/78—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Transplantation (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT05772622T 2004-07-29 2005-07-20 1,1a,5,5a-tetrahydro-3-thia- cyclopropaäaüpentalene: trizyklische thiophenderivate als s1p1/edg1-rezeptor-agonisten ATE409697T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2004/008501 WO2006010379A1 (en) 2004-07-29 2004-07-29 Novel thiophene derivatives as immunosuppressive agents

Publications (1)

Publication Number Publication Date
ATE409697T1 true ATE409697T1 (de) 2008-10-15

Family

ID=34958296

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05772622T ATE409697T1 (de) 2004-07-29 2005-07-20 1,1a,5,5a-tetrahydro-3-thia- cyclopropaäaüpentalene: trizyklische thiophenderivate als s1p1/edg1-rezeptor-agonisten

Country Status (23)

Country Link
US (1) US7750040B2 (de)
EP (1) EP1805163B1 (de)
JP (1) JP4807884B2 (de)
KR (1) KR20070046849A (de)
CN (1) CN1993346B (de)
AR (1) AR050273A1 (de)
AT (1) ATE409697T1 (de)
AU (1) AU2005266529A1 (de)
BR (1) BRPI0513841A (de)
CA (1) CA2574305A1 (de)
DE (1) DE602005010109D1 (de)
DK (1) DK1805163T3 (de)
ES (1) ES2313391T3 (de)
IL (1) IL180962A0 (de)
MX (1) MX2007000972A (de)
NO (1) NO20071095L (de)
PL (1) PL1805163T3 (de)
PT (1) PT1805163E (de)
RU (1) RU2386626C2 (de)
SI (1) SI1805163T1 (de)
TW (1) TW200616994A (de)
WO (2) WO2006010379A1 (de)
ZA (1) ZA200700535B (de)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4678139B2 (ja) * 2004-05-10 2011-04-27 トヨタ自動車株式会社 自動車の暖房制御システム
WO2006010379A1 (en) 2004-07-29 2006-02-02 Actelion Pharmaceuticals Ltd. Novel thiophene derivatives as immunosuppressive agents
JP2008509931A (ja) 2004-08-13 2008-04-03 プレーシス ファーマスーティカルズ インコーポレイテッド スフィンゴシン−１−ホスフェート（ｓ１ｐ）レセプター活性を調節するための方法および組成物
US7846964B2 (en) * 2005-03-23 2010-12-07 Actelion Pharmaceuticals Ltd. Thiophene derivatives as spingosine-1-phosphate-1 receptor agonists
EP1863787B1 (de) 2005-03-23 2011-05-25 Actelion Pharmaceuticals Ltd. Hydrierte benzo[c]thiophenderivate als immunmodulatoren
CN101146529B (zh) 2005-03-23 2012-08-29 埃科特莱茵药品有限公司 新颖噻吩衍生物作为鞘氨醇-1-磷酸酯-1受体激动剂
CA2612661A1 (en) * 2005-06-24 2006-12-28 Actelion Pharmaceuticals Ltd. Novel thiophene derivatives
AR057894A1 (es) * 2005-11-23 2007-12-26 Actelion Pharmaceuticals Ltd Derivados de tiofeno
TWI404706B (zh) * 2006-01-11 2013-08-11 Actelion Pharmaceuticals Ltd 新穎噻吩衍生物
JP5063615B2 (ja) 2006-01-24 2012-10-31 アクテリオン ファーマシューティカルズ リミテッド 新規ピリジン誘導体
TWI408139B (zh) 2006-09-07 2013-09-11 Actelion Pharmaceuticals Ltd 新穎噻吩衍生物
MY149853A (en) * 2006-09-07 2013-10-31 Actelion Pharmaceuticals Ltd Pyridin-4-yl derivatives as immunomodulating agents
CL2007002594A1 (es) * 2006-09-08 2008-06-06 Actelion Pharmaceuticals Ltd Compuestos derivados de piridin-3-il, agentes inmunomoduladores; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en el tratamiento de enfermedades asociadas con un sistema inmunologico activado. .
DE102007019679B4 (de) 2006-11-06 2025-04-30 Carl Zeiss Meditec Ag Operationsmikroskop mit OCT-System
DE102007019680A1 (de) 2006-11-06 2008-05-08 Carl Zeiss Surgical Gmbh Ophthalmo-Operationsmikroskop mit OCT-System
DE102007019677A1 (de) 2006-11-06 2008-05-08 Carl Zeiss Surgical Gmbh Operationsmikroskop mit OCT-System und Operationsmikroskop-Beleuchtungsmodul mit OCT-System
DK2125797T3 (da) * 2007-03-16 2014-02-10 Actelion Pharmaceuticals Ltd Aminopyridinderivater som s1p1/edg1-receptoragonister
WO2009011850A2 (en) * 2007-07-16 2009-01-22 Abbott Laboratories Novel therapeutic compounds
CA2706834A1 (en) * 2007-12-10 2009-06-18 Actelion Pharmaceuticals Ltd Thiophene derivatives as agonists of s1p1/edg1
WO2009074969A2 (en) * 2007-12-12 2009-06-18 University Of Lausanne Sphingosine-1-phosphate, analogs and antagonists for use as medicaments
WO2009109906A1 (en) * 2008-03-06 2009-09-11 Actelion Pharmaceuticals Ltd Pyridine compounds
SI2252609T1 (sl) * 2008-03-07 2013-07-31 Actelion Pharmaceuticals Ltd. Derivati piridin-2-ila kot imunomodulacijska sredstva
KR101718639B1 (ko) 2008-03-17 2017-03-21 액테리온 파마슈티칼 리미티드 선별적 ｓ1ｐ₁ 수용체 작동약에 대한 투약 섭생
RU2503680C2 (ru) 2008-07-15 2014-01-10 Санофи-Авентис ОКСАЗОЛОПИРИМИДИНЫ КАК АГОНИСТЫ РЕЦЕПТОРА Edg-1
CN104311472B9 (zh) 2008-07-23 2020-03-17 艾尼纳制药公司 经取代的1,2,3,4-四氢环戊并[b]吲哚-3-基乙酸衍生物
US8415484B2 (en) 2008-08-27 2013-04-09 Arena Pharmaceuticals, Inc. Substituted tricyclic acid derivatives as S1P1 receptor agonists useful in the treatment of autoimmune and inflammatory disorders
DE102009002514A1 (de) 2009-04-21 2010-10-28 Evonik Degussa Gmbh Verfahren zur Herstellung von substituierten 1,4-Chinonmethiden
CA2767585C (en) 2009-07-16 2017-09-26 Actelion Pharmaceuticals Ltd Pyridin-4-yl derivatives
SG10201404925TA (en) * 2009-08-28 2014-10-30 Arena Pharm Inc Cannabinoid receptor modulators
SG10201500639TA (en) 2010-01-27 2015-03-30 Arena Pharm Inc Processes for the preparation of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid and salts thereof
EP2542554B1 (de) 2010-03-03 2015-11-04 Arena Pharmaceuticals, Inc. Verfahren zur herstellung von s1p1-rezeptormodulatoren und kristallinen formen davon
MX350009B (es) 2011-01-19 2017-08-23 Idorsia Pharmaceuticals Ltd Derivados de 2-metoxi-piridin-4-ilo.
WO2012116277A1 (en) 2011-02-25 2012-08-30 Arena Pharmaceuticals, Inc. Cannabinoid receptor modulators
SI2885266T1 (sl) 2012-08-17 2020-10-30 Actelion Pharmaceuticals Ltd Postopek za pripravo (2Z,5Z)-5-(3-kloro-4-((R)-2,3-dihidroksipropoksi) benziliden)-2-(propilimino)-3-(O-tolil)tiazolidin-4-on in v omenjenem postopku uporabljena vmesna spojina
DE102013208091B4 (de) 2013-05-02 2019-05-09 Carl Zeiss Ag Vorrichtung und Verfahren zum Vermessen einer Flächentopografie
DE102014222629A1 (de) 2014-11-05 2016-05-12 Carl Zeiss Meditec Ag Untersuchen eines Objekts mit OCT-Abtastlichtstrahlen
DE202014011051U1 (de) 2014-11-05 2017-07-26 Carl Zeiss Meditec Ag Vorrichtung für das Untersuchen eines Patientenauges
DE202014011050U1 (de) 2014-11-05 2017-07-26 Carl Zeiss Meditec Ag Vorrichtung für das Untersuchen eines Patientenauges
ES2995737T3 (en) 2015-01-06 2025-02-11 Arena Pharm Inc Compound for use in treating conditions related to the s1p1 receptor
KR102220848B1 (ko) 2015-05-20 2021-02-26 이도르시아 파마슈티컬스 리미티드 화합물 (s)-3-｛4-[5-(2-시클로펜틸-6-메톡시-피리딘-4-일)-[1,2,4]옥사디아졸-3-일]-2-에틸-6-메틸-페녹시｝-프로판-1,2-디올의 결정형
US10111841B2 (en) 2015-06-19 2018-10-30 University Of South Florida Stabilization of alcohol intoxication-induced cardiovascular instability
MA42807A (fr) 2015-06-22 2018-07-25 Arena Pharm Inc Sel l-arginine cristallin d'acide (r)-2-(7-(4-cyclopentyl-3-(trifluorométhyl)benzyloxy)-1,2,3,4-tétrahydrocyclo-penta[b]indol-3-yl)acétique (composé 1) pour une utilisation dans des troubles associés au récepteur de s1p1
CA3053416A1 (en) 2017-02-16 2018-08-23 Arena Pharmaceuticals, Inc. Compounds and methods for treatment of inflammatory bowel disease with extra-intestinal manifestations
WO2018151873A1 (en) 2017-02-16 2018-08-23 Arena Pharmaceuticals, Inc. Compounds and methods for treatment of primary biliary cholangitis
WO2018208848A1 (en) 2017-05-08 2018-11-15 Arena Pharmaceuticals, Inc. Compounds and methods for treatment of visceral pain
CA3062444A1 (en) * 2017-05-19 2018-11-22 Etna-Tec, Ltd Methods for making functionalized fluorinated monomers, fluorinated monomers, and compositions for making the same
EP3801459B1 (de) 2018-06-06 2024-08-07 Arena Pharmaceuticals, Inc. Verfahren zur behandlung von erkrankungen im zusammenhang mit dem s1p1-rezeptor
WO2020051378A1 (en) 2018-09-06 2020-03-12 Arena Pharmaceuticals, Inc. Compounds useful in the treatment of autoimmune and inflammatory disorders
US11014940B1 (en) 2018-10-16 2021-05-25 Celgene Corporation Thiazolidinone and oxazolidinone compounds and formulations
US11013723B1 (en) 2018-10-16 2021-05-25 Celgene Corporation Solid forms of a thiazolidinone compound, compositions and methods of use thereof
US11014897B1 (en) 2018-10-16 2021-05-25 Celgene Corporation Solid forms comprising a thiazolidinone compound, compositions and methods of use thereof
US11186556B1 (en) 2018-10-16 2021-11-30 Celgene Corporation Salts of a thiazolidinone compound, solid forms, compositions and methods of use thereof
CN113072519A (zh) * 2021-04-01 2021-07-06 福建海西新药创制有限公司 一种利用微反应装置连续生产非布司他的方法

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2599740B1 (fr) 1986-06-05 1988-08-12 Rhone Poulenc Sante Derives de benzo(b)thiophene de benzo(b)furannecarboxamides, leurs procedes de preparation et les medicaments les contenant
US4963557A (en) 1987-09-28 1990-10-16 Smithkline Beecham Corporation Immunomodulatory azaspiranes
AU7686891A (en) 1990-04-05 1991-10-30 American National Red Cross, The A protein family related to immediate-early protein expressed by human endothelial cells during differentiation
AU653957B2 (en) 1990-09-20 1994-10-20 Merrell Dow Pharmaceuticals Inc. 1-aryl-3-pyridinyl-2-propene-1-ones
EP1070080A4 (de) 1998-03-09 2004-12-29 Smithkline Beecham Corp MENSCHLICHE EDG-1c POLYNUCLEOTIDE UND POLYPEPTIDE SOWIE IHRE ANWENDUNGEN
GB9808665D0 (en) * 1998-04-23 1998-06-24 Merck Sharp & Dohme Therapeutic compounds
JP2005501841A (ja) 2001-08-01 2005-01-20 バセル ポリオレフィン ジーエムビーエイチ 複素環式ペンタレン誘導体の製造方法
US20040058894A1 (en) * 2002-01-18 2004-03-25 Doherty George A. Selective S1P1/Edg1 receptor agonists
DE60330047D1 (en) 2002-01-18 2009-12-24 Merck & Co Inc "n-(benzyl)aminoalkyl carboxylate, phosphinate, phosphonate und tetrazole als edg rezeptoragonisten"
AU2003276043A1 (en) 2002-06-17 2003-12-31 Merck & Co., Inc. 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)pyrrolidine-3-carboxylates as edg receptor agonists
DE10231370B4 (de) 2002-07-11 2006-04-06 Sanofi-Aventis Deutschland Gmbh Thiophenglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel
AU2003259296A1 (en) * 2002-07-30 2004-02-16 University Of Virginia Patent Foundation Compounds active in spinigosine 1-phosphate signaling
WO2004035538A1 (en) 2002-10-15 2004-04-29 Merck & Co., Inc. Process for making azetidine-3-carboxylic acid
US20060252741A1 (en) 2003-05-15 2006-11-09 Colandrea Vincent J 3-(2-amino-1-azacyclyl)-5-aryl-1,2,4-oxadiazoles as s1p receptor agonists
TW200505416A (en) 2003-08-12 2005-02-16 Mitsubishi Pharma Corp Bi-aryl compound having immunosuppressive activity
CN1859908A (zh) 2003-10-01 2006-11-08 默克公司 作为s1p受体激动剂的3,5－芳基、杂芳基或环烷基取代的－1,2,4－噁二唑类化合物
CA2547198A1 (en) 2003-12-17 2005-06-30 Merck & Co., Inc. (3,4-disubstituted)propanoic carboxylates as s1p (edg) receptor agonists
WO2006010379A1 (en) 2004-07-29 2006-02-02 Actelion Pharmaceuticals Ltd. Novel thiophene derivatives as immunosuppressive agents
EP1863787B1 (de) 2005-03-23 2011-05-25 Actelion Pharmaceuticals Ltd. Hydrierte benzo[c]thiophenderivate als immunmodulatoren
US7846964B2 (en) 2005-03-23 2010-12-07 Actelion Pharmaceuticals Ltd. Thiophene derivatives as spingosine-1-phosphate-1 receptor agonists
CN101146529B (zh) 2005-03-23 2012-08-29 埃科特莱茵药品有限公司 新颖噻吩衍生物作为鞘氨醇-1-磷酸酯-1受体激动剂
EP1893591A1 (de) 2005-06-08 2008-03-05 Novartis AG Polycyclische oxadiazole oder isoxazole und deren verwendung als sip-rezeptorliganden
CA2612661A1 (en) 2005-06-24 2006-12-28 Actelion Pharmaceuticals Ltd. Novel thiophene derivatives
AR057894A1 (es) 2005-11-23 2007-12-26 Actelion Pharmaceuticals Ltd Derivados de tiofeno
GB0601744D0 (en) 2006-01-27 2006-03-08 Novartis Ag Organic compounds
US20080005421A1 (en) 2006-05-19 2008-01-03 Chi-Tung Chang Switching Device of Input and Output Interfaces of Computer Systems
EP2109364A4 (de) 2006-12-15 2010-04-14 Abbott Lab Neuartige oxadiazolverbindungen
WO2008091967A1 (en) 2007-01-26 2008-07-31 Smithkline Beecham Corporation Chemical compounds

Also Published As

Publication number Publication date
RU2007107164A (ru) 2008-09-10
PL1805163T3 (pl) 2009-04-30
WO2006010379A1 (en) 2006-02-02
AR050273A1 (es) 2006-10-11
EP1805163A2 (de) 2007-07-11
IL180962A0 (en) 2007-07-04
US20080064740A1 (en) 2008-03-13
BRPI0513841A (pt) 2008-05-20
PT1805163E (pt) 2008-12-05
NO20071095L (no) 2007-02-27
DK1805163T3 (da) 2008-12-15
ZA200700535B (en) 2008-10-29
WO2006010544A2 (en) 2006-02-02
CA2574305A1 (en) 2006-02-02
AU2005266529A1 (en) 2006-02-02
TW200616994A (en) 2006-06-01
JP2008508210A (ja) 2008-03-21
CN1993346A (zh) 2007-07-04
DE602005010109D1 (de) 2008-11-13
EP1805163B1 (de) 2008-10-01
US7750040B2 (en) 2010-07-06
RU2386626C2 (ru) 2010-04-20
CN1993346B (zh) 2011-04-27
ES2313391T3 (es) 2009-03-01
WO2006010544A3 (en) 2006-03-30
JP4807884B2 (ja) 2011-11-02
MX2007000972A (es) 2007-04-10
KR20070046849A (ko) 2007-05-03
SI1805163T1 (sl) 2009-02-28

Similar Documents

Publication Publication Date Title
ATE409697T1 (de) 1,1a,5,5a-tetrahydro-3-thia- cyclopropaäaüpentalene: trizyklische thiophenderivate als s1p1/edg1-rezeptor-agonisten
DK1863474T3 (da) Hidtil ukendte thiophenderivater som sphingosin-1-phosphat-1-receptoragonister
IL192657A0 (en) Novel thiophene derivatives as s1p1/edg1 receptor agonists
MY149869A (en) Thiophene derivatives as s1p1/edg1 receptor agonists
DK1720836T3 (da) 6-substituerede 2,3,4,5-tetrahydro-1h-benzo [d]azepiner som 5-ht2c-receptoragonister
ZA200709086B (en) Novel thiophene derivatives as sphingosine-1-phosphate-1 receptor agonists
DK2206710T3 (da) Indolderivater som s1p1-receptor agonister
IL177799A0 (en) Substituted thiophene derivatives as anti-cancer agents
LTPA2017005I1 (lt) Nauji junginiai, kaip opioido receptoriaus moduliatoriai
BRPI0418052A2 (pt) derivados de ciclohexano espiro-cíclicos com afinidade para o receptor orl1
DK1668014T3 (da) Kondenserede heterocykliske forbindelser som serotoninreceptormodulatorer
DOP2007000080A (es) Piridin [3,4-b] pirazinonas
NO20070494L (no) Substituerte azepinderivater som serotoninreseptormodulatorer
ATE465995T1 (de) N-'(1,5-diphenyl-1h-pyrazol-3- yl)sulfonamidderivate mit affinität zum cb1- rezeptor
DK1924561T3 (da) 6-arylalkylamino-2,3,4,5-tetrahydro-1h-benzo[d]azepiner as 5-ht2c-receptor agonister
DE602006020447D1 (de) Niacin-rezeptoragonisten, zusammensetzungen mit de
DK1833791T3 (da) 2,3,4,9-tetrahydor-1H-carbazolderivater som CRTH2 receptorantagonister
DK2094684T3 (da) 1,5-diphenyl-3-benzylamino-1,5-dihydropyrrolidin-2-on som CB1-receptor modulatorer
ATE396724T1 (de) 1h-thieno 2,3-c-pyrazol-derivate als kinase-i- hemmer
EP1811842A4 (de) 3,3'-diindolylmethan immunaktivierende zusammensetzungen
ATE445604T1 (de) Neue 2,6-diaminopyridin-3-on-derivate
HK1098748A (en) Substituted thiophene derivatives as anti-cancer agents
ES1061924Y (es) Lampara basculante empotrable, para balizamiento.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1805163

Country of ref document: EP

REN Ceased due to non-payment of the annual fee